A prospectus was filed on 26 June to raise up to $125,000,000: http://investors.biotapharma.com/secfiling.cfm?filingid=1437749-15-12974&CIK=72444 Money raised is to be used for general corporate purposes.
PV1 Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response